[1]
“Stability Indicating RP-HPLC Method Development for the Estimation of Molnupiravir in Capsule Dosage Form”, Int. J. Pharm. Sci. Drug Res., vol. 15, no. 3, pp. 222–228, May 2023, doi: 10.25004/IJPSDR.2023.150301.